Related Experiment Video
Updated: Aug 30, 2026

A Computational Pipeline for Intergenic/Intragenic Enhancer RNA Quantification in Mouse Embryonic Stem Cells
Published on: October 28, 2025
Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity
Motoko Unoki1, Yusuke Nakamura
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Abstract:
We previously demonstrated several lines of evidence indicating that early growth response 2 (EGR2) functions as a tumor suppressor, partly on the basis that its expression was often decreased in human tumors and cancer cell lines. Here we report a possible molecular mechanism to account for down-regulation of EGR2 in tumor cells. Although no genetic mutations in the gene or alterations in methylation status of its promoter were detected, we found a high degree of methylation at CpG islands in intron 1 of EGR2 in cell lines that were expressing this gene at a high level. Moreover, reporter gene experiments revealed that methylated intron 1 had somehow conferred enhancer-like activity. The data imply the existence of a previously unsuspected mechanism of gene expression regulation.
Insights
Early growth response 2 (EGR2) acts as a tumor suppressor. Methylation in EGR2 intron 1 surprisingly enhances gene expression, revealing a novel regulatory mechanism in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Early growth response 2 (EGR2) is recognized as a tumor suppressor.
- Reduced EGR2 expression is frequently observed in human tumors and cancer cell lines.
Purpose of the Study:
- To elucidate the molecular mechanisms behind EGR2 down-regulation in tumor cells.
- To investigate the role of DNA methylation in EGR2 gene expression regulation.
Main Methods:
- Analysis of EGR2 gene mutations and promoter methylation status.
- Assessment of CpG island methylation within EGR2 intron 1.
- Reporter gene assays to evaluate the impact of intron 1 methylation on gene activity.
Main Results:
- No genetic mutations or promoter methylation changes were found in EGR2.
- High methylation levels were detected in CpG islands within intron 1 of EGR2.
- Methylated intron 1 exhibited enhancer-like activity in reporter gene experiments.
Conclusions:
- A novel gene expression regulatory mechanism involving intron methylation has been identified.
- This mechanism may contribute to the down-regulation of the tumor suppressor EGR2 in cancer cells.
- Further research into this epigenetic regulation is warranted for cancer therapy development.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

